Andreas H Groll Selected Research

OMPI

1/2002

Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas H Groll Research Topics

Disease

32	Infections 12/2021 - 03/2002
26	Neoplasms (Cancer) 09/2022 - 03/2006
26	Mycoses (Diseases, Fungus) 01/2022 - 03/2002
22	Invasive Fungal Infections 10/2019 - 03/2002
15	Aspergillosis 01/2022 - 01/2002
12	Hematologic Neoplasms (Hematological Malignancy) 09/2021 - 07/2009
12	Neutropenia 03/2021 - 09/2007
12	Candidiasis (Moniliasis) 08/2013 - 05/2002
10	Body Weight (Weight, Body) 12/2019 - 01/2002
9	Fever (Fevers) 08/2020 - 12/2009
8	Invasive Pulmonary Aspergillosis 01/2022 - 01/2002
7	Leukemia 09/2021 - 01/2017
6	Communicable Diseases (Infectious Diseases) 05/2021 - 03/2012
5	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020 - 01/2004
4	Lymphoma (Lymphomas) 09/2021 - 03/2014
4	Pulmonary Aspergillosis 07/2015 - 01/2002
4	Invasive Candidiasis 08/2013 - 12/2005
3	Sepsis (Septicemia) 07/2021 - 10/2019
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 01/2020
3	Agranulocytosis (Granulocytopenia) 01/2021 - 03/2008
3	Bone Marrow Failure Disorders 02/2017 - 07/2009
2	Clinical Deterioration 12/2021 - 07/2021
2	Toxoplasmosis 03/2021 - 01/2018
2	Recurrent respiratory papillomatosis 01/2021 - 11/2014
2	Colitis 01/2021 - 01/2015
2	Papilloma (Papillomatosis) 01/2021 - 11/2014
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2020
2	Candidemia 12/2020 - 01/2017
2	Breakthrough Infections 12/2019 - 03/2006
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 02/2014
2	Necrosis 08/2017 - 04/2017
2	Exanthema (Rash) 12/2009 - 03/2002
2	Lung Injury 06/2003 - 01/2002
2	Pulmonary Infarction 06/2002 - 01/2002
1	Autoimmune Diseases (Autoimmune Disease) 12/2021
1	Dysgammaglobulinemia 09/2021
1	Sarcoma (Soft Tissue Sarcoma) 04/2021

Drug/Important Bio-Agent (IBA)

15	liposomal amphotericin B FDA Link 12/2020 - 06/2002
12	Pharmaceutical PreparationsIBA 09/2021 - 01/2002
10	EchinocandinsIBA 01/2022 - 01/2002
10	Antifungal AgentsIBA 01/2022 - 07/2009
10	posaconazole FDA Link 01/2021 - 01/2004
10	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2020 - 01/2002
9	Voriconazole (Vfend)FDA LinkGeneric 10/2017 - 03/2002
9	Micafungin (FK463)FDA Link 07/2015 - 06/2002
8	galactomannanIBA 12/2021 - 01/2002
7	TriazolesIBA 01/2019 - 06/2003
7	Caspofungin (Cancidas)FDA Link 04/2013 - 01/2002
5	AntigensIBA 12/2021 - 01/2002
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 10/2019
5	Biomarkers (Surrogate Marker)IBA 10/2019 - 04/2013
5	Fluconazole (Zonal)FDA LinkGeneric 12/2012 - 10/2004
4	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021 - 04/2013
3	Monoclonal AntibodiesIBA 09/2021 - 04/2017
3	Rituximab (Mabthera)FDA Link 09/2021 - 08/2017
3	Imatinib Mesylate (Gleevec)FDA Link 09/2021 - 02/2014
3	SuspensionsIBA 09/2020 - 08/2002
3	isavuconazoleIBA 01/2019 - 01/2017
2	polyglucosanIBA 12/2021 - 11/2016
2	Inotuzumab OzogamicinIBA 09/2021 - 03/2021
2	NivolumabIBA 09/2021 - 03/2021
2	blinatumomabIBA 09/2021 - 03/2021
2	Chimeric Antigen ReceptorsIBA 09/2021 - 03/2021
2	pembrolizumabIBA 09/2021 - 03/2021
2	Basiliximab FDA Link 03/2021 - 08/2017
2	IpilimumabIBA 03/2021 - 08/2017
2	Alemtuzumab (Campath)FDA Link 03/2021 - 08/2017
2	Abatacept (Orencia)FDA Link 03/2021 - 08/2017
2	Anti-Infective Agents (Microbicides)IBA 03/2021 - 02/2012
2	Bevacizumab (Avastin)FDA Link 01/2021 - 11/2014
2	Acyclovir (Aciclovir)FDA LinkGeneric 10/2019 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 08/2017 - 04/2017
2	CytokinesIBA 04/2017 - 08/2013
2	AzolesIBA 07/2015 - 03/2014
2	PolyenesIBA 12/2012 - 12/2003
2	BilirubinIBA 01/2012 - 03/2002
2	2- amino- 4- methylenecyclopentane- 1- carboxylic acidIBA 05/2005 - 10/2004
2	Isoleucine-tRNA LigaseIBA 05/2005 - 10/2004
2	ER 30346 (ravuconazole)IBA 04/2004 - 06/2003
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2022
1	Surface-Active Agents (Surfactants)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	Tyrosine Kinase InhibitorsIBA 09/2021
1	nilotinib FDA Link 09/2021
1	Dasatinib (BMS 354825)FDA Link 09/2021
1	inolimomabIBA 03/2021
1	Immune Checkpoint InhibitorsIBA 03/2021
1	ofatumumab FDA Link 03/2021
1	Gemtuzumab (Mylotarg)FDA Link 03/2021

Therapy/Procedure

40	Therapeutics 12/2021 - 01/2002
26	Hematopoietic Stem Cell Transplantation 03/2021 - 01/2004
16	Drug Therapy (Chemotherapy) 12/2021 - 01/2004
10	Cell Transplantation 09/2022 - 03/2020
9	Stem Cell Transplantation 02/2020 - 01/2008
7	Transplantation 12/2021 - 01/2004
4	Catheters 12/2020 - 05/2010
3	Chemoprevention 01/2019 - 03/2012
3	Salvage Therapy 01/2006 - 01/2004
2	Central Venous Catheters 01/2021 - 01/2011
1	Neoadjuvant Therapy 04/2021